Qing Yuan Li
Finanzdirektor/CFO bei CytoPharm, Inc.
Profil
Qing Yuan Li is currently the President, CFO, Director & IR Contact at CytoPharm, Inc. He previously worked as a Director at Merit Biotech, Inc. Dr. Li holds a doctorate degree from Colorado State University and an undergraduate degree from National Taiwan University.
Aktive Positionen von Qing Yuan Li
| Unternehmen | Position | Beginn |
|---|---|---|
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Finanzdirektor/CFO | 22.09.2011 |
Ehemalige bekannte Positionen von Qing Yuan Li
| Unternehmen | Position | Ende |
|---|---|---|
| MERIT BIOTECH INC | Direktor/Vorstandsmitglied | - |
Ausbildung von Qing Yuan Li
| Colorado State University | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERIT BIOTECH INC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
